Pharma Walks Out, Red Tape Gone Mad, Oracle Skyrockets
Join Neil Woodford and Jon Adair as they discuss the week’s most significant market stories. In this episode, Neil shares his insights on Merck’s decision to halt its billion-pound research centre in London, central bank rate decisions, China’s latest stimulus measures, and Larry Ellison’s unprecedented wealth gain. Discover why bond yields are returning to previous levels and what this means for investors.
Subscribe to W4.0 for more in-depth financial discussions and insights. If you’re a W4.0 member, send in your questions for next week’s episode!
🔗 Read more on W4.0: https://www.w4pz.com
More episodes
Why Neil Woodford Won’t Buy the Anthropic IPO
The Anthropic IPO is weeks away, and its filing shows a business like no other: $17bn of sales in three months, still a loss, and $895bn signed away on computing power. Neil Woodford goes through the numbers and asks who actually keeps the profit from AI.
Show notesBritain Can Grow Its Way Out of This Budget
Budget 2026 raised the tax on your savings and rental income, on top of a rise already due in April, and the Chancellor barely mentioned it. Neil Woodford explains why John Healey did it, and why he thinks the official forecast that says more tax rises are coming is wrong.
Show notesThe AI Boom Is Only in the Foothills
AI stocks sold off hard last week, and the Financial Times called it a dress rehearsal for an AI reckoning. Is the AI bubble about to burst? Neil Woodford thinks the AI boom is only in the foothills, but he has a clear view on who is holding the risk if it doesn’t pay for itself.
Show notesGo deeper than the podcast
Access the strategies, research, and real-time portfolio data behind the conversations.
